What Is S Gin Urinalysisand Its Clinical Importance

Published

Table of Contents

Specific gravity (SG) in urinalysis serves as a critical biomarker for evaluating kidney function, hydration status, and underlying pathological conditions. As a key indicator of urine concentration, SG reflects the nephron’s ability to regulate solute and water balance, influenced by hormonal mechanisms such as antidiuretic hormone (ADH). Abnormal SG readings can signal disorders ranging from diabetes insipidus to chronic kidney disease, making its accurate measurement essential for clinical diagnosis. This discussion explores the physiological foundations of SG, its measurement methodologies, and its pivotal role in distinguishing renal pathologies.

The assessment of SG integrates both laboratory techniques and clinical interpretation, requiring precision to avoid misdiagnosis. Refractometry and dipstick tests remain the primary tools for quantification, each with distinct advantages and limitations. Understanding the interplay between SG trends and osmolality further refines diagnostic accuracy, particularly in acute kidney injury. Additionally, pre-analytical errors and interferences—such as proteinuria or radiocontrast agents—demand rigorous quality control to ensure reliable results. By examining these elements, clinicians can leverage SG as a foundational element in fluid management and renal health monitoring.

what is s.g in urinalysis

Definition and Basic Concept of Specific Gravity in Urinalysis

Specific Gravity (SG) in urinalysis refers to the measurement of urine density relative to water, expressed as a dimensionless ratio (typically ranging from 1.000 to 1.040). Scientifically termed urine specific gravity, it quantifies the concentration of dissolved solutes (e.g., urea, electrolytes, glucose) and suspended particles in urine, providing critical insights into kidney function, hydration status, and underlying renal pathologies. The measurement reflects the nephron’s ability to concentrate or dilute urine, a process tightly regulated by hormonal and physiological mechanisms.

SG serves as a non-invasive biomarker for evaluating renal concentrating ability, fluid balance, and systemic conditions such as diabetes insipidus, dehydration, or overhydration. Its clinical utility extends beyond hydration assessment to diagnosing tubular dysfunction, obstructive nephropathy, and electrolyte imbalances. The test is routinely performed using refractometry or urine dipsticks, with values interpreted in conjunction with other urinalysis parameters (e.g., osmolality, urine color).

Scientific Basis and Role in Kidney Function Assessment

The kidney’s primary function in urine concentration involves the countercurrent multiplier system in the nephron’s loop of Henle and the collecting duct, where antidiuretic hormone (ADH, or vasopressin) modulates water reabsorption. SG reflects the osmotic pressure gradient created by solute retention (e.g., urea, sodium) and water reabsorption, with higher SG indicating concentrated urine and lower SG indicating dilute urine.

Key physiological mechanisms include:

  • ADH Release: Triggered by osmoreceptors in the hypothalamus, ADH increases water permeability in the collecting duct via aquaporin-2 channels, enhancing urine concentration.
  • Nephron Function: The medullary osmotic gradient (generated by the loop of Henle) enables the kidney to produce urine with SG up to 1.030–1.040 under normal conditions.
  • Pathological Disruptions: Conditions like diabetes insipidus (ADH deficiency) or chronic kidney disease (tubular damage) impair concentrating ability, leading to isosthenuria (fixed SG ~1.010), a hallmark of renal insufficiency.

    • Clinical Interpretation of SG Values and Associated Conditions

    SG values are categorized into three primary ranges, each correlating with distinct physiological or pathological states. The following table summarizes interpretations, with clinical examples provided for clarity:
    SG Range Clinical Interpretation Associated Conditions Physiological Mechanism
    <1.005 Dilute urine; indicates overhydration or impaired concentrating ability.
    • Psychogenic polydipsia (excessive water intake).
    • Diabetes insipidus (central or nephrogenic).
    • Post-obstructive diuresis (after relief of urinary obstruction).
    • Early chronic kidney disease (CKD) with tubular dysfunction.
    Low SG (<1.005) reflects inadequate ADH activity or solvent diuresis, where urine osmolality approaches that of plasma (~280–290 mOsm/kg).
    1.005–1.030 Normal range; urine concentration varies with hydration status.
    • Normal hydration in healthy individuals.
    • Mild dehydration (early stages).
    • Compensated renal concentrating defects (e.g., mild interstitial nephritis).
    Normal SG reflects dynamic regulation by ADH and medullary solute gradients, with values fluctuating based on fluid intake and renal perfusion.
    >1.030 Concentrated urine; suggests dehydration or pre-renal azotemia.
    • Dehydration (e.g., gastrointestinal losses, diuretics, hemorrhage).
    • Pre-renal acute kidney injury (AKI) due to hypoperfusion.
    • Syndrome of inappropriate antidiuretic hormone secretion (SIADH).
    • Glomerular disease (e.g., acute glomerulonephritis with oliguria).
    High SG (>1.030) indicates maximal ADH-mediated water reabsorption or solvent loss, often accompanied by elevated urine osmolality (>800 mOsm/kg).
    Fixed at ~1.010 (Isosthenuria) Loss of concentrating/diluting ability; indicative of renal parenchymal disease.
    • Chronic kidney disease (CKD) stages 3–5.
    • Advanced pyelonephritis or interstitial nephritis.
    • Post-contrast nephropathy.
    Isosthenuria arises from destruction of medullary interstitial gradients or ADH resistance, where urine osmolality equals plasma osmolality (~300 mOsm/kg).

    Physiological Mechanisms of SG Regulation: ADH and the Nephron

    The regulation of SG is a multifactorial process governed by hormonal, cellular, and hemodynamic interactions within the nephron. Below are the key components:

    1. Antidiuretic Hormone (ADH) Pathway
    ADH, synthesized in the supraoptic and paraventricular nuclei of the hypothalamus, is released from the posterior pituitary in response to:

  • Increased plasma osmolality (detected by osmoreceptors).
  • Decreased effective circulating volume (via baroreceptors in the carotid sinus and atrial stretch receptors).

    • Upon binding to V2 receptors in the collecting duct principal cells, ADH triggers:

  • Insertion of aquaporin-2 (AQP2) channels into the apical membrane, facilitating water reabsorption.
  • Urea transporter (UT-A1) upregulation, enhancing medullary solute retention to sustain the osmotic gradient.

    • 2. Medullary Osmotic Gradient
    The loop of Henle establishes a hypertonic interstitium via:

  • Active NaCl reabsorption in the thick ascending limb (via NKCC2 cotransporters).
  • Urea recycling from the inner medullary collecting duct (via UT-A1).
    • This gradient enables the collecting duct to concentrate urine to 1.030–1.040 under maximal ADH stimulation.

    3. Countercurrent Exchange
    The vasa recta (peritubular capillaries) maintains the medullary gradient by:

  • Slow blood flow minimizing solute washout.
  • Countermurrent exchange preserving the hypertonic environment.

    • 4. Pathological Disruptions

  • ADH Deficiency (Central Diabetes Insipidus): Genetic mutations (e.g., AVPR2 gene) or pituitary damage impair ADH signaling, leading to dilute urine (SG <1.005).
  • ADH Resistance (Nephrogenic Diabetes Insipidus): Mutations in AQP2 or UT-A1 genes prevent water reabsorption, resulting in fixed low SG despite high ADH levels.
  • Renal Parenchymal Disease: Interstitial fibrosis or tubular injury disrupts the medullary gradient, causing isosthenuria.

    • Example Case:
    A patient with SIADH (e.g., due to small cell lung cancer) presents with SG >1.030 despite euvolemia, reflecting inappropriate ADH secretion leading to water retention and concentrated urine. Conversely, a patient with CKD stage 4 may exhibit isosthenuria (SG ~1.010) due to loss of medullary concentrating ability.

    what is s.g in urinalysis - Ilustrasi 2

    Methods for Measuring Specific Gravity in Clinical Urinalysis

    Specific gravity (SG) in urinalysis is a critical parameter for assessing renal concentrating and diluting abilities, hydration status, and potential urinary tract disorders. Clinical laboratories employ two primary methods for SG measurement: refractometry and urine dipstick tests, each with distinct operational principles, accuracy profiles, and limitations. While refractometry remains the gold standard due to its precision and broad applicability, dipstick tests offer rapid, cost-effective alternatives for point-of-care settings. Understanding the procedural nuances, comparative advantages, and potential pitfalls of these methods is essential for ensuring reliable diagnostic outcomes and minimizing procedural errors.

    The selection of a measurement method hinges on factors such as laboratory workflow, resource availability, and the clinical context. Refractometry, though more expensive and technically demanding, provides quantitative results unaffected by non-glucose, non-protein solutes, making it ideal for comprehensive evaluations. Conversely, dipstick tests, while prone to interference from specific substances, are favored in high-throughput environments or resource-limited settings. Below, the operational principles, procedural workflows, and comparative analysis of these methods are detailed, alongside guidelines for implementing robust quality control protocols.

    Principles of Refractometry for SG Measurement

    Refractometry exploits the principle of light refraction through a solution, where the degree of bending (refractive index) correlates directly with the concentration of dissolved solutes in urine. The refractive index of urine is influenced primarily by solutes such as urea, sodium, potassium, and creatinine, with glucose and proteins contributing minimally unless present in pathological concentrations. Modern refractometers utilize a prism-based optical system that measures the critical angle of light refraction when passing from air into the urine sample, converting this angle into a numerical SG value.

    The accuracy of refractometry depends on several factors:

  • Temperature compensation: Most clinical refractometers automatically adjust for temperature variations (typically calibrated to 20°C), as refractive indices are temperature-dependent.
  • Sample clarity: Turbid or hemolyzed urine may scatter light, leading to erroneous readings. Pre-analytical filtration or centrifugation is often required.
  • Calibration standards: Regular verification against certified reference materials (e.g., distilled water for SG 1.000 and a standardized urine control) ensures precision.
    • Key Principle:
    The refractive index (n) of urine is defined as the ratio of the speed of light in a vacuum to its speed in the urine sample. For clinical purposes, SG is derived from the refractive index using the formula:
    SG ≈ (n – 1) × 133.42 (valid for urine SG range of 1.000–1.040).

    Step-by-Step Procedure for Refractometer-Based SG Measurement

    The procedural workflow for refractometry involves sample preparation, instrument calibration, and result interpretation. Adherence to standardized steps minimizes variability and ensures compliance with Clinical Laboratory Improvement Amendments (CLIA) or equivalent regulatory standards.

    Sample Preparation and Instrument Setup
    1. Sample collection: Urine should be collected in a clean, dry container and mixed thoroughly to ensure homogeneity. Midstream clean-catch specimens are preferred to avoid contamination.
    2. Pre-analytical handling:

  • Centrifuge the sample at 1,500–2,000 × g for 5 minutes if turbid or particulate-laden to remove debris.
  • For highly viscous or lipid-rich samples (e.g., chyluria), dilute with distilled water (1:1 ratio) and adjust the reading by subtracting 0.001 SG per dilution step.
    • 3. Instrument calibration:
  • Power on the refractometer and allow it to stabilize (typically 15–30 minutes).
  • Clean the prism surface with 70% isopropyl alcohol and a lint-free wipe, then rinse with distilled water.
  • Perform a zero calibration using distilled water (SG 1.000). If the reading deviates by >0.002, recalibrate or service the instrument.
  • Verify calibration using a commercial urine control with a known SG (e.g., 1.010 and 1.030). Acceptable deviation: ±0.003 SG.

    • Measurement Execution
    1. Apply the sample: Place 2–3 drops of prepared urine onto the prism, ensuring full coverage without overflow.
    2. Close the cover: Secure the cover to prevent light leakage and allow the sample to equilibrate (typically 30–60 seconds).
    3. Read the scale: Observe the meniscus formed at the boundary of the light/dark interface on the calibrated scale. The SG value is read where the meniscus intersects the scale.
    4. Record and interpret:

  • Normal SG range: 1.005–1.030 (varies with hydration status).
  • Low SG (<1.005): Indicates overhydration, diabetes insipidus, or renal tubular dysfunction.
  • High SG (>1.030): Suggests dehydration, glycosuria, or radiocontrast exposure.

    • Post-Analytical Checks

  • Reproducibility: Repeat the measurement with a fresh sample if the first reading varies by >0.005 SG.
  • Documentation: Record the SG value alongside other urinalysis parameters (e.g., pH, protein) for clinical correlation.

    • Principles and Limitations of Urine Dipstick Tests for SG

    Urine dipstick tests measure SG indirectly via polyelectrolyte-based pads that change color in response to ionic concentration. These pads contain a mixture of polyelectrolytes (e.g., polyacrylic acid) that swell in proportion to the urine’s solute load, altering the reflectance of light. The color reaction is compared to a standardized chart to estimate SG, typically in increments of 0.005–0.010.

    Advantages of Dipstick Tests

  • Rapid results: Color development occurs within 30–60 seconds, making it suitable for point-of-care testing.
  • Cost-effective: Disposable strips reduce instrument maintenance costs and are ideal for low-resource settings.
  • Multiparameter assessment: Most dipsticks combine SG with pH, protein, glucose, and other analytes in a single test.

    • Limitations and Interferences

  • Non-linear response: Accuracy declines at SG extremes (<1.010 or >1.030), where color gradients may not correlate precisely with actual values.
  • Substance-specific interference:
  • Proteins: High concentrations (>30 g/L) can falsely elevate SG readings by up to 0.005 due to increased refractive properties.
  • Glucose: Concentrations >200 mg/dL may elevate SG by 0.001–0.003, though modern strips mitigate this effect.
  • Radiocontrast agents: Iodinated contrast media can artificially increase SG by 0.005–0.010.
  • Ketones: Acetoacetate and acetone may cause slight overestimation (<0.002 SG).
  • Temperature sensitivity: Color development is optimal at room temperature (20–25°C); extreme temperatures may alter results.
  • Lot-to-lot variability: Different manufacturers may exhibit slight differences in color scales, requiring periodic verification with reference methods.
    • Critical Note:
    Dipstick SG readings should never replace refractometry for diagnostic purposes, particularly in cases of suspected renal pathology, severe dehydration, or metabolic disorders. They serve as a screening tool rather than a definitive measurement.

    Comparative Analysis of Refractometry and Dipstick Tests

    The selection between refractometry and dipstick tests depends on clinical requirements, laboratory infrastructure, and cost constraints. Below is a structured comparison of their operational and analytical characteristics.
    Parameter Refractometry Dipstick Tests
    Measurement Principle Optical refraction of light through urine solutes. Polyelectrolyte-induced color change proportional to ionic concentration.
    Accuracy Range ±0.002 SG (high precision across 1.000–1.040 range). ±0.005–0.010 SG (reduced accuracy at extremes).
    Interference Sources Turbidity, lipids, high viscosity (requires sample prep). Proteins, glucose, ketones, radiocontrast, temperature.
    Quantitative vs. Semi-Quantitative Direct numerical readout (e.g., 1.020). Colorimetric scale (e.g.,

    Clinical Significance and Pathological Associations of Specific Gravity in Urinalysis

    Specific gravity (SG) serves as a critical diagnostic marker in urinalysis, reflecting the kidney’s ability to concentrate or dilute urine in response to fluid and electrolyte balance. Abnormal SG patterns—whether fixed, inappropriately low, or persistently high—provide insights into underlying pathological processes, including endocrine disorders, renal dysfunction, and systemic fluid imbalances. This section explores the key pathological associations of abnormal SG, its role in differentiating acute kidney injury (AKI) etiologies, and red flags necessitating urgent re-evaluation. Additionally, the clinical utility of SG in monitoring fluid therapy efficacy across diverse patient populations is examined, with evidence-based target ranges for optimization.

    Pathological Conditions Linked to Abnormal Specific Gravity Levels

    Abnormal SG values are strongly associated with specific pathological conditions, often reflecting disturbances in antidiuretic hormone (ADH) regulation, tubular dysfunction, or systemic fluid overload/depletion. Below are the primary conditions correlated with altered SG, categorized by their underlying pathophysiology.

    Endocrine and Fluid Regulatory Disorders

    • Diabetes Insipidus (DI)
      SG in DI is typically <1.005 due to impaired ADH secretion (central DI) or renal resistance to ADH (nephrogenic DI). Patients present with polyuria (>3 L/day) and polydipsia, with urine osmolality consistently <300 mOsm/kg despite dehydration. Central DI may follow pituitary surgery or trauma, while nephrogenic DI arises from genetic mutations (e.g., AVPR2 or AQP2 defects) or lithium toxicity.
    • Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
      SG is typically >1.030 due to excessive ADH activity, leading to urine concentration despite euvolemia or hypervolemia. Common causes include ectopic ADH production (e.g., small cell lung cancer), central nervous system disorders (e.g., stroke, meningitis), or drug-induced (e.g., SSRIs, carbamazepine). Serum sodium <135 mEq/L with inappropriately concentrated urine (osmolality >100 mOsm/kg) confirms the diagnosis.

    Renal Pathologies

    • Chronic Kidney Disease (CKD)
      Progressive loss of concentrating ability results in a fixed SG (~1.010) due to tubular atrophy and impaired medullary gradient maintenance. Advanced CKD (eGFR <30 mL/min/1.73 m²) often exhibits isosthenuria (SG ≈ 1.010), reflecting loss of both diluting and concentrating capacity. Concurrent proteinuria and hematuria further support renal parenchymal damage.
    • Acute Tubular Necrosis (ATN)
      Early ATN may present with low SG (<1.010) due to impaired concentrating mechanisms, while later stages show fixed SG as tubular function declines. Differentiation from prerenal AKI relies on urine indices: ATN exhibits fractional excretion of sodium (FeNa) >2% and urine osmolality <350 mOsm/kg despite oliguria.

    Systemic and Prerenal Conditions

    • Prerenal Azotemia
      SG >1.030 reflects maximal renal concentration in response to hypovolemia or effective circulating volume depletion (e.g., heart failure, cirrhosis, hemorrhage). Urine sodium <20 mEq/L and osmolality >500 mOsm/kg support prerenal etiology, whereas a rise in blood urea nitrogen (BUN):creatinine ratio (>20:1) indicates prerenal dominance.
    • Postrenal Obstruction
      Early obstruction may yield high SG (>1.020) due to initial compensatory concentration, but prolonged stasis leads to fixed SG (~1.010) as tubular function deteriorates. Hydronephrosis on imaging and elevated creatinine with low urine output further confirm the diagnosis.
    SG trends, when correlated with urine osmolality and electrolyte profiles, aid in classifying AKI into prerenal, intrinsic (renal), or postrenal causes. Below is a structured approach to interpretation:
    AKI Category Specific Gravity Pattern Urine Osmolality Key Differentiating Features
    Prerenal AKI >1.030 (early); may normalize with rehydration >500 mOsm/kg
    • Urine sodium <20 mEq/L (suggests tubular reabsorption).
    • FeNa <1% and BUN:creatinine >20:1.
    • Resolves with fluid resuscitation.
    Intrinsic AKI (ATN) Low (<1.010) or fixed (~1.010) <350 mOsm/kg (despite oliguria)
    • Urine sodium >40 mEq/L (tubular injury).
    • FeNa >2% and granular/muddy brown casts.
    • Persistent despite fluid therapy.
    Postrenal AKI Variable: initially >1.020; progresses to fixed (~1.010) Variable; may be <350 mOsm/kg with obstruction >48 hours
    • Hydronephrosis on imaging.
    • Urine sodium >20 mEq/L if obstruction is prolonged.
    • Relief of obstruction restores renal function.
    Critical Note: Overlap exists in early AKI phases; urine osmolality and electrolyte studies (e.g., FeNa, urine/plasma creatinine ratio) are essential for definitive classification.

    Red Flags in Urinalysis Requiring Urgent Re-evaluation of Specific Gravity

    Certain SG findings mandate immediate reassessment to identify life-threatening conditions or therapeutic failures. Below are high-priority red flags, categorized by clinical urgency:
    • Discrepancy Between High SG and Low Urine Osmolality
      A SG >1.025 with urine osmolality <300 mOsm/kg suggests:
      • Laboratory error (e.g., reagent strip inaccuracy; confirm with refractometry).
      • Severe hyperglycemia (osmotic diuresis masks true concentration; adjust SG by subtracting 0.003 for every 100 mg/dL glucose above normal).
      • Early renal tubular dysfunction (e.g., ATN or interstitial nephritis).
    • Persistent Low SG (<1.010) Despite Clinical Dehydration
      Indicates:
      • Diabetes insipidus (central or nephrogenic).
      • Advanced CKD with isosthenuria.
      • Drug-induced nephrogenic DI (e.g., lithium, foscarnet).
      Action: Measure serum ADH levels, perform water deprivation test, and rule out medications/toxins.
    • Fixed SG (~1.010) in Acute Setting with Rising Creatinine
      Suggests:
      • Intrinsic AKI (ATN, glomerulonephritis).
      • Postrenal obstruction with tubular damage.
      • Severe hypokalemia or hypercalcemia impairing concentrating ability.
    • High SG (>1.030) with Hyposthenuria (Osmolality <100 mOsm/kg)
      Strongly implies:
      • SIADH (serum Na+ <135 mEq/L).
      • Psychogenic polydipsia with inappropriate ADH

        what is s.g in urinalysis - Ilustrasi 3

        Artifacts, Interferences, and Common Pitfalls in Specific Gravity Testing

        Specific gravity (SG) measurement in urinalysis is a critical diagnostic tool for assessing renal concentrating ability, hydration status, and underlying pathologies. However, inaccuracies in SG readings—whether falsely elevated or depressed—can arise from pre-analytical errors, sample contamination, or interference by endogenous or exogenous substances. These artifacts may lead to misdiagnosis, particularly in conditions such as chronic kidney disease (CKD), diabetes insipidus, or post-contrast studies. Understanding the sources of interference and implementing corrective measures ensures reliable interpretation of SG results in clinical practice.

        Pre-Analytical Errors Affecting SG Measurements

        Pre-analytical variables represent the most common sources of SG inaccuracies, often introduced during sample collection, storage, or handling. Improper techniques can systematically alter SG readings, complicating clinical decision-making. Below are key pre-analytical errors categorized by their impact on SG values.

        Errors Leading to False Elevation of SG

        Incorrect handling or contamination can artificially increase SG readings, masking underlying renal dysfunction or dehydration. Common causes include:
        • Improper sample dilution: Diluting urine with distilled water or other fluids (e.g., during catheterization) reduces osmolality but may not proportionally lower SG if proteins or glucose are present, leading to a disproportionately high reading.
        • Delayed testing with bacterial contamination: Prolonged storage at room temperature allows bacterial growth, which metabolizes urea into ammonia, increasing SG due to higher solute concentration. This effect is particularly pronounced in alkaline urine.
        • Evaporation during transport: Open containers or improperly sealed urine specimens lose water through evaporation, concentrating solutes and elevating SG. This is common in outpatient samples left unrefrigerated.
        • Contamination with blood or mucus: Hematuria or vaginal secretions introduce proteins or cells that increase osmolality without corresponding water loss, falsely raising SG.
        • Residual disinfectants or cleaning agents: Traces of chlorine, iodine, or quaternary ammonium compounds (e.g., from catheter cleaning) can mimic solute concentration, elevating SG readings.

        Errors Leading to False Depression of SG

        Conversely, improper handling can underestimate SG, obscuring conditions like overhydration or renal tubular dysfunction. Key contributors include:
        • Excessive dilution with sterile saline or irrigation fluids: Post-cystoscopy or post-surgery samples may be diluted with isotonic solutions, artificially lowering SG to ~1.010, even in concentrated urine.
        • Sample leakage or overflow: During centrifugation or transfer, loss of concentrated sediment (e.g., crystals, casts) reduces total solute mass, depressing SG.
        • Improper refrigeration: Cold temperatures can precipitate proteins or glucose, altering the refractive index and yielding falsely low SG readings.
        • Contamination with radiocontrast media: Iodinated or gadolinium-based contrast agents dissociate into ions, increasing osmolality but disrupting refractometer calibration, often resulting in SG values <1.005.
        • Urine specimen mixing errors: Accidental mixing of first-void and midstream samples can dilute SG if the first void contains high solute concentration (e.g., after fasting).

        Interferences from Endogenous and Exogenous Substances

        Certain physiological and pharmacological substances interfere with SG measurement by altering the refractive index or reacting with dipstick reagents. These interferences are particularly problematic in refractometry and semi-quantitative dipstick methods.

        Substances Causing False Elevation of SG

        • High-proteinuria (>30 g/L): Proteins (e.g., albumin, Bence Jones proteins) scatter light differently than small solutes, causing refractometers to overestimate SG. Dipstick methods may also yield false positives due to protein error of indicators.
        • Glucose >10 mmol/L: Hyperglycemia increases osmolality, but refractometers may misinterpret glucose’s refractive properties as higher SG. Dipstick glucose reactions can also interfere with pH-based SG estimation.
        • Radiopaque contrast media (e.g., iohexol, iopamidol): These agents dissociate into ions, increasing osmolality but disrupting refractometer calibration, leading to SG readings >1.030 despite isosthenuria.
        • Urobilinogen or bilirubin: High concentrations (>0.5 mg/dL) can alter light absorption, causing refractometers to overestimate SG in jaundiced patients.
        • Mannitol or glycerol infusion: Osmotic diuretics increase urine osmolality without proportional water loss, elevating SG to >1.030 in patients with normal renal function.

        Substances Causing False Depression of SG

        • Radiocontrast media (e.g., gadolinium, iodinated agents): These agents dissociate into free ions, overwhelming refractometer sensors and yielding SG <1.005, even in concentrated urine.
        • High urea concentrations in diabetes insipidus: Pure water diuresis (e.g., central DI) produces urine with low osmolality but may retain urea, causing refractometers to underestimate SG due to urea’s lower refractive index compared to other solutes.
        • Alcohol or ethylene glycol ingestion: These substances increase osmolality but have unique refractive properties, leading refractometers to underreport SG despite high solute load.
        • Detergents or soaps (residual contamination): Traces of anionic surfactants (e.g., from catheter lubricants) can lower surface tension, altering light refraction and depressing SG readings.
        • Severe glycosuria with ketonuria: In uncontrolled diabetes, ketones (e.g., acetoacetate) may interfere with refractometer calibration, yielding SG <1.010 despite hyperglycemia.

        Validation of SG Results in Conflict with Clinical Findings

        Discrepancies between SG and other urinalysis parameters (e.g., high SG with isosthenuria in CKD) require systematic validation to avoid diagnostic errors. Below is a step-by-step guide to resolving conflicts, prioritizing urine osmolality as the gold standard for renal concentrating ability.

        Step-by-Step Validation Protocol

        1. Assess clinical context: Review patient history (e.g., CKD, diabetes, recent contrast exposure) and symptoms (e.g., polyuria, polydipsia) to identify potential interferences.
        2. Reperform SG measurement:
          • Use a calibrated refractometer with fresh, well-mixed urine. Avoid samples with visible contamination (blood, mucus, or lipids).
          • For dipstick methods, confirm with a reagent strip from a different manufacturer to rule out lot-specific errors.
        3. Measure urine osmolality: Obtain a direct osmolality reading (mOsm/kg) using a vapor pressure osmometer. Compare with SG:
          Normal range: 300–900 mOsm/kg (varies with hydration status).

          Isosthenuria: Osmolality ~300 mOsm/kg despite SG >1.010 (indicates fixed renal concentrating defect, e.g., CKD stage 4–5).

          Discrepancy threshold: If SG >1.020 but osmolality <350 mOsm/kg, suspect interference (e.g., radiocontrast, proteinuria).

        4. Quantify interfering substances:
          • Check for proteinuria (>30 g/L) via sulfosalicylic acid precipitation or 24-hour urine collection.
          • Test for glucose (>10 mmol/L) with a chemistry analyzer to confirm refractometer interference.
          • Screen for radiocontrast agents if recent imaging was performed (e.g., CT urogram).
        5. Correlate with other urinalysis findings:
          • In

            Specific gravity in urinalysis emerges as a cornerstone of renal assessment, bridging physiological function with clinical pathology. From distinguishing prerenal azotemia to monitoring fluid therapy efficacy, SG provides actionable insights into hydration status and kidney integrity. While artifacts and interferences necessitate careful validation, adherence to standardized protocols enhances diagnostic confidence. Ultimately, mastering SG interpretation empowers clinicians to refine patient care, ensuring timely interventions for conditions like diabetes insipidus or chronic kidney disease. This foundational parameter remains indispensable in both routine and critical care settings.

            FAQ

            What does SG stand for in a urinalysis test?

            SG stands for specific gravity, a measure of urine concentration that compares urine density to water. It helps assess kidney function, hydration status, and conditions like diabetes or dehydration. Normal values typically range from 1.005 to 1.030.

            What does SG mean in my urinalysis results?

            SG in urinalysis results indicates how concentrated your urine is, reflecting how well your kidneys are filtering waste. A low SG (below 1.005) may signal overhydration, while a high SG (above 1.030) could suggest dehydration or kidney issues.

            What is SG in a urine sample?

            SG (specific gravity) in a urine sample measures the ratio of urine density to distilled water, showing how much solutes (like salts, glucose) are dissolved. It’s a key indicator of kidney function and hydration, often tested using a refractometer or dipstick.

            What does SG mean in a urine sample?

            SG in a urine sample refers to specific gravity, a numerical value showing urine concentration. It helps diagnose problems like kidney disease, diabetes insipidus, or improper hydration, with normal ranges usually between 1.003 and 1.030.

            What does SG mean on a urine test result of 1.030?

            An SG of 1.030 on a urine test is at the higher end of normal, indicating well-concentrated urine, which is typical after fasting or exercise. It suggests adequate hydration but could also reflect dehydration if symptoms like thirst or dark urine are present.

            What is SG in a urine test?

            SG in a urine test is specific gravity, a measure of urine concentration that evaluates kidney function and hydration. It’s calculated by comparing urine density to water, with values outside 1.005–1.030 often requiring further medical review.

            Leave a Comment

            Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Voltefac.